umr glp-1 coverage of Obesity Therapies in State-Regulated Markets GLP-1s and The Payer Predicament

Drinking more water helps curb cravings and improves digestion

In the STEP 1 trial, 86% of participants lost at least 5% of their body weight, and 50% lost 15% or more

however, if more time has passed, its recommended to skip the missed dose and resume the next scheduled one

The effects of microdosing GLP-1s have not been clinically tested, and these doses are not FDA approved, Dr

Ozempic, Mounjaro, and Rybelsus have been covered under Medicare Part D when prescribed for diabetes

Importantly, the deal doesnt automatically lower prices for everyone: private insurance plans can decide whether or not to adopt the new pricing, and standard pharmacy routes may not reflect these discounts right away